ebola - search results

A psychiatric facility in Freetown has stepped away from its colonial past and removed these ‘shackles’ from their patients.

Afrigen Biologics, a Cape Town pharmaceutical company, has made Africa’s first COVID jab as part of the World Health Organisation’s mRNA vaccine technology transfer hub. How did they do it and what’s next?

Africa is building up a genomic surveillance network of 12 regional hubs that will help the continent to prepare for future pandemics.

Africa is building up its own vaccine manufacturing capacity which will make the continent less dependent on wealthy nations for vaccine supply.

African countries are still struggling for COVID-19 vaccines. One reason for this is the misconception that the continent wasn’t hard-hit by the pandemic. But the numbers tell a different story.

Checkpoints in the scientific system are put in place to ensure that research can be sped up in a safe way. But during the COVID pandemic, the accelerated timeline to push research out in an effort to help has exposed gaps in the process that allow bad science to slip through.

COVID variants are new versions of the virus that are smarter at surviving. But before we can understand what these changed forms mean for vaccines, we first need to go back to the basics. We take you through the evolution of the virus and what this means for your body’s defences.

South Africa is on the verge of rolling out COVID vaccines widely, but can we vaccinate children and pregnant women, and which jabs work against the 501Y.V2 variants identified in South Africa? We asked the epidemiologist and former ministerial advisory committee chairperson, Salim Adbool Karim.

Now that the world has its first effective COVID jabs, the next challenge we have to tackle is who gets them? Here’s why the public could be key to answering this complex question in South Africa.

Mathematicians are exploring models to figure out how COVID vaccines should be distributed to have the biggest impact. Should they give it to older people to prevent deaths or to young adults - the main spreaders - to slow down infection rates? 

Three journalists and a scientist unpack how the coronavirus pandemic changed their jobs and the news landscape. Watch the discussion here.

When it comes to leadership and innovation, there's much that industrialised nations can learn.

With hundreds of potential COVID vaccine candidates being tested around the world, here’s a quick guide to which ones you should keep an eye on — and when we could see results.

One of South Africa’s three COVID-19 vaccine trials was recently put on hold after a participant in the United Kingdom developed an unexplained illness. After an independent review, AstraZeneca’s candidate, which was considered to be a frontrunner in the field, is expected to resume locally this week. But results are still a long shot for this year, says the trial’s lead investigator.

This medicine has been shown to slash COVID recovery times by more than a quarter. But will It become available in South Africa — and if so, who will be allowed to get it? Find out in this simple explainer. 

Experts fear the COVID-19 pandemic may set gender equality back decades. Here, seven women explain the struggles it has brought and their hopes for the future